References
- Olsen TG, Heegaard S. Orbital lymphoma. Surv Ophthalmol. 2019;64(1):45–66.
- Yu H, Du YX, Sun ZC, et al. Clinical features and treatment outcomes of primary ocular adnexal mucosa-associated lymphoid tissue lymphoma: a single center retrospective analysis of 64 patients in China. Int J Ophthalmol. 2019;12(11):1731–1736.
- Bayraktar S, Bayraktar UD, Stefanovic A, et al. Primary ocular adnexal MALT lymphoma: single institution experience in a large cohort of patients. Br J Haematol. 2011;152(1):72–80.
- Stefanovic A, Lossos IS. Extranodal Marginal zone lymphoma of the ocular adnexa. Blood. 2009;114(3):501–510.
- Swerdlow SH, Campo E, Harris NL, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. Revised 4th ed. Lyon, France: International Agency for Research in Cancer (IARC); 2017.
- Yen MT, Bilyk JR, Wladis EJ, et al. Treatments for ocular adnexal lymphoma: a report by the American Academy of Ophthalmology. Ophthalmology. 2018;125(1):127–136.
- Desai A, Joag MG, Lekakis L, et al. Long-term course of patients with primary ocular adnexal MALT lymphoma: a large single-institution cohort study. Blood. 2017;129(3):324–332.
- Dhakal B, Fenske TS, Ramalingam S, et al. Local disease control in ocular adnexal lymphoproliferative disorders: comparative outcomes of MALT versus non-MALT histologies. Clin Lymphoma Myeloma Leuk. 2017;17(5):305–311.
- Olsen G, Holm F, Mikkelsen LM, et al. Orbital lymphoma – an international multicenter retrospective study. Am J Ophthalmol. 2019;199:44–57.
- Arkenau H-T, Chong G, Cunningham D, et al. The role of intrathecal chemotherapy prophylaxis in patients with diffuse large B-cell lymphoma. Ann Oncol. 2007;18(3):541–545.
- Schmitz N, Zeynalova S, Nickelsen M, et al. CNS International Prognostic Index: a risk model for CNS relapse in patients with diffuse large B-cell lymphoma treated with R-CHOP. J Clin Oncol. 2016;34(26):3150–3156.